e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Biomarkers of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of Hypoxia-Inducible Factor (HIF)-1a and Asymmetric Dimethylarginine(ADMA) in patients with COPD and controls.
K. Upadhyay (New Delhi, India), A. Ali (New Delhi, India), B. Pattnaik (New Delhi, India), A. Agarwal (New Delhi, India), R. Guleria (New Delhi, India)
Source:
International Congress 2018 – Biomarkers of COPD
Session:
Biomarkers of COPD
Session type:
Thematic Poster
Number:
4077
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Upadhyay (New Delhi, India), A. Ali (New Delhi, India), B. Pattnaik (New Delhi, India), A. Agarwal (New Delhi, India), R. Guleria (New Delhi, India). Association of Hypoxia-Inducible Factor (HIF)-1a and Asymmetric Dimethylarginine(ADMA) in patients with COPD and controls.. 4077
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly.
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020
Serum transforming growth factor –β1 (TGF-β1) in asthmatics: Association between disease control, severity and duration
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
The impact of ß-blockers in non–small cell lung cancer patients treated with Epidermal Growth Factor Receptor Kinase Inhibitors, Taiwan NHIRD database study.
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
Effects of Pulmonary Rehabilitation (PR) on Exercise Capacity (EC) and Quality of Life (QOL) in Indian Patients with Severe COPD
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Recruitment of Dendritic Cells by Factor XIII (FXIII) facilitates the immune response in COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Macrophage subsets in lung tissue of healthy controls and asthma patients
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Cognitive Function in COPD and controls
Source: International Congress 2019 – More and more COPD
Year: 2019
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
Insulin-Like Growth Factors and IGF-Binding Proteins levels in serum from smokers and patients with different grades of COPD, COPD and lung cancer and exacerbated COPD
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
Treatment compliance in patients with Asthma, COPD and Mixed Asthma-COPD.
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Macrophage migration inhibitory factor (MIF), a biomarker in COPD?
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Association of candidate genes with FeNO in asthma: preliminary results from the Gene Environment Interactions in Respiratory Diseases (GEIRD) study.
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
The asthma-COPD overlap syndrome: Transcription factors GATA3 and STAT6 as possible markers
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Relationship between endothelial dysfunction and GOLD stage in patients with COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept